Temporal dependence of in vivo USPIO-enhanced MRI signal changes in human carotid atheromatous plaques
暂无分享,去创建一个
S. P. S. Howarth | J. Gillard | A. Patterson | S. Howarth | M. Graves | U. Sadat | S. Walsh | T. Tang | J. Boyle | J. U-King-im | M. Gaunt | V. Young | S. R. Miller | Z. Li | T. Y. Tang | A. J. Patterson | M. J. Graves | J. M. U-King-Im | Z. Y. Li | U. Sadat | V. E. Young | S. R. Walsh | J. R. Boyle | M. E. Gaunt | J. H. Gillard | J. Boyle | Jonathan R. Boyle | Tjun Y. Tang | Andrew J. Patterson | Martin J. Graves | Stewart R. Walsh | Sam R. Miller | Zhi-Yong Li
[1] M. Wise,et al. Negative power functions of time in pharmacokinetics and their implications , 1985, Journal of Pharmacokinetics and Biopharmaceutics.
[2] M. E. Kooi,et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.
[3] Martin J Graves,et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[4] C. Yuan,et al. Visualization of Fibrous Cap Thickness and Rupture in Human Atherosclerotic Carotid Plaque In Vivo With High-Resolution Magnetic Resonance Imaging , 2000, Circulation.
[5] Ildikó Kriszbacher,et al. Inflammation, atherosclerosis, and coronary artery disease. , 2005, New England Journal of Medicine.
[6] O. Baffa,et al. MRI relaxometry: methods and applications , 2006 .
[7] J. Gillard,et al. Noninvasive imaging of carotid plaque inflammation , 2004, Neurology.
[8] J. Gillard,et al. Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals. , 2009, European journal of radiology.
[9] J. Gillard,et al. Identifying Inflamed Carotid Plaques Using In Vivo USPIO-Enhanced MR Imaging to Label Plaque Macrophages , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[10] Fabien Hyafil,et al. Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[11] J. Debatin,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.
[12] F. A. Seiler,et al. Numerical Recipes in C: The Art of Scientific Computing , 1989 .
[13] A. Olukotun,et al. Phase I clinical evaluation of a new iron oxide MR contrast agent , 1994, Journal of magnetic resonance imaging : JMRI.
[14] Martin J Graves,et al. In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultrasmall Superparamagnetic Particles of Iron Oxide–Enhanced MRI , 2004, Stroke.
[15] M. Weiss,et al. Use of gamma distributed residence times in pharmacokinetics , 2004, European Journal of Clinical Pharmacology.
[16] Martin J Graves,et al. Assessment of Inflammatory Burden Contralateral to the Symptomatic Carotid Stenosis Using High-Resolution Ultrasmall, Superparamagnetic Iron Oxide–Enhanced MRI , 2006, Stroke.
[17] Florian M Vogt,et al. Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide , 2006, Journal of magnetic resonance imaging : JMRI.
[18] William H. Press,et al. Numerical recipes in C. The art of scientific computing , 1987 .
[19] R. Willette,et al. Differential uptake of ferumoxtran‐10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: Critical determinants of atherosclerotic plaque labeling , 2005, Journal of magnetic resonance imaging : JMRI.